WHO: Frequently asked questions and considerations for the introduction of hexavalent vaccine DTwP-HepB-Hib-IPV in routine immunization programmes (June 2024)

Published on June 27, 2024

In March 2024, WHO prequalified a new hexavalent combination vaccine (DTwP-HepB-Hib-IPV), which includes whole-cell pertussis and inactivated polio antigen components. This vaccine aims to reduce the number of injections in immunization schedules and enhance protection against poliomyelitis. Available through UNICEF Supply Division, Gavi offers grants to eligible countries for its introduction. WHO's SAGE recommends at least two doses of IPV in routine schedules alongside OPV, essential for global polio eradication. The new hexavalent vaccine supports achieving this recommendation while minimizing the number of injections for children. To read more about the new hexavalent combination vaccine, access the attached document!

media_com_khub_uploaded_15115_Hexavalent_FAQs_EN_June_2024.pdf
Other news

(CALL FOR NOMINATIONS) Gavi Civil Society Organization (CSO) Committee

June 27, 2024
Join the Gavi CSO Steering Committee! Vacancies open on the Gavi Civil Society Organization (CSO)Constituency Steering Committee. Deadline for nominations: 14th July, 2024 11:59 EA-Time Are you passionate about ensuring universal access to life-saving vaccines and health services? Do you want to play a crucial role in shaping global health policies and advocating for equitable healthcare?

IA2030 In-Depth Review on Access to Immunization in MICs

June 27, 2024
Children in middle-income countries, which do not receive support from Gavi, the Vaccine Alliance, lack the necessary immunization protection. Annually, 66 million children, representing half of the world's newborns, are born in these nations, and 25% of them do not receive all essential vaccines. Achieving 90% coverage of the vaccines targeted by the Immunization Agenda 2030 (IA2030) in these cou